Morgan Stanley’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $4.01M | Buy |
|
|||||
|
2022
Q3 | $77K | Sell |
|
|||||
|
2022
Q2 | $105K | Sell |
|
|||||
|
2022
Q1 | $571K | Sell |
|
|||||
|
2021
Q4 | $1.15M | Buy |
|
|||||
|
2021
Q3 | $406K | Buy |
|
|||||
|
2021
Q2 | $117K | Sell |
|
|||||
|
2021
Q1 | $101K | Buy |
|
|||||
|
2020
Q4 | $68K | Sell |
|
|||||
|
2020
Q3 | $80K | Buy |
|
|||||
|
2020
Q2 | $69K | Buy |
|
|||||
|
2020
Q1 | $44K | Buy |
|
|||||
|
2019
Q4 | $51K | Buy |
|
|||||
|
2019
Q3 | $43K | Sell |
|
|||||
|
2019
Q2 | $297K | Buy |
|
|||||
|
2019
Q1 | $26K | Buy |
|
|||||
|
2018
Q4 | $21K | Sell |
|
|||||
|
2018
Q3 | $41K | Buy |
|
|||||
|
2018
Q2 | $7K | Buy |
|
|||||
|
2018
Q1 | $7K | Sell |
|
|||||
|
2017
Q4 | $81K | Buy |
|
|||||
|
2017
Q3 | $107K | Buy |
|